申请人:Schambye Hans T.
公开号:US20080300180A1
公开(公告)日:2008-12-04
The present invention relates to new growth hormone secretagogue receptor 1A (GHS-R 1A) ligands, and pharmaceutical compositions comprising any of the new GHS-R1 A ligands. The ligands are suitable for a wide range of applications, and thus the present invention also relates to use of the GHS-R1 A ligands according to the present invention in the manufacture of a medicament for the treatment of an individual in need thereof. In another aspect, the present invention relates to a method of treatment of an individual in need thereof, comprising administering to said individual one or more of the GHS-R1A ligands disclosed herein, such as e.g. for treatment of cancer cachexia.
本发明涉及新型生长激素促分泌素受体1A(GHS-R 1A)配体,以及包含任何此类新型GHS-R1A配体的药物组合物。这些配体适用于广泛的应用范围,因此本发明还涉及根据本发明的GHS-R1A配体在制造用于治疗有此需要的个体的药物中的用途。在另一方面,本发明涉及一种治疗有此需要的个体的方法,包括向该个体施用本文披露的一种或多种GHS-R1A配体,例如用于治疗癌症恶病质。